Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Mona Abaza

Concepts (150)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Otolaryngology
10
2021
72
3.820
Why?
Voice Disorders
9
2017
21
2.110
Why?
Personnel Selection
4
2019
66
1.680
Why?
Internship and Residency
8
2019
947
1.680
Why?
Larynx
4
2015
44
0.960
Why?
Physicians, Women
1
2021
49
0.890
Why?
Leadership
2
2021
296
0.740
Why?
Treatment Adherence and Compliance
1
2017
22
0.690
Why?
Resilience, Psychological
1
2018
93
0.650
Why?
Career Choice
1
2018
206
0.620
Why?
Deglutition Disorders
1
2017
119
0.610
Why?
Injections
1
2015
164
0.580
Why?
Simulation Training
1
2015
54
0.560
Why?
Education, Medical
1
2018
244
0.560
Why?
Voice
2
2017
13
0.530
Why?
Burnout, Professional
1
2018
252
0.520
Why?
Education, Medical, Undergraduate
1
2016
170
0.520
Why?
Patient Care Team
1
2017
526
0.490
Why?
Occupational Diseases
2
2006
145
0.480
Why?
Vocal Cords
4
2006
28
0.480
Why?
Carcinoma, Hepatocellular
2
2020
182
0.470
Why?
Hepatitis C
2
2020
205
0.440
Why?
Liver Neoplasms
2
2020
447
0.400
Why?
Education, Medical, Graduate
3
2019
379
0.390
Why?
Inhibin-beta Subunits
1
2006
5
0.330
Why?
Activins
1
2006
25
0.320
Why?
Schistosomiasis
1
2006
34
0.310
Why?
Job Application
2
2015
12
0.290
Why?
Insulin-Like Growth Factor I
1
2006
277
0.270
Why?
Postpoliomyelitis Syndrome
1
2001
4
0.230
Why?
Glypicans
1
2020
2
0.220
Why?
Dipeptidyl Peptidase 4
1
2020
9
0.220
Why?
Neurofibromatosis 2
2
1998
3
0.210
Why?
Humans
25
2021
112255
0.210
Why?
Equipment Design
2
2015
530
0.200
Why?
Voice Quality
2
2014
18
0.200
Why?
Pilot Projects
2
2019
1406
0.200
Why?
Disability Evaluation
1
2000
305
0.190
Why?
United States
4
2019
12170
0.180
Why?
Otolaryngologists
1
2017
9
0.180
Why?
Speech-Language Pathology
1
2017
20
0.170
Why?
Organizational Culture
1
2018
128
0.170
Why?
Educational Status
1
2019
406
0.170
Why?
Interviews as Topic
1
2019
628
0.160
Why?
Clinical Clerkship
1
2016
76
0.150
Why?
Faculty, Medical
1
2018
240
0.150
Why?
Psychoses, Substance-Induced
2
2007
20
0.150
Why?
Competitive Behavior
1
2015
43
0.150
Why?
Speech Acoustics
1
2014
12
0.140
Why?
Dysphonia
1
2014
12
0.140
Why?
Female
13
2021
62627
0.140
Why?
Electromyography
3
2007
328
0.140
Why?
Egypt
2
2020
10
0.140
Why?
School Admission Criteria
1
2013
29
0.130
Why?
Cell Division
1
1996
880
0.130
Why?
Clinical Competence
2
2019
904
0.130
Why?
Program Evaluation
1
2018
859
0.130
Why?
Educational Measurement
1
2016
300
0.130
Why?
Attitude
1
2015
228
0.130
Why?
Correspondence as Topic
1
2012
15
0.130
Why?
Surgeons
1
2015
140
0.130
Why?
Students, Medical
1
2016
272
0.120
Why?
Writing
1
2012
79
0.120
Why?
Societies, Medical
1
2016
764
0.110
Why?
Male
13
2018
60721
0.110
Why?
Nasal Decongestants
2
2007
9
0.100
Why?
Anti-Ulcer Agents
2
2007
16
0.100
Why?
Histamine H1 Antagonists
2
2007
36
0.100
Why?
Biomedical Research
1
2015
605
0.090
Why?
Vocal Cord Paralysis
2
2005
21
0.080
Why?
Music
1
2006
33
0.080
Why?
Analgesics
1
2007
151
0.080
Why?
Movement Disorders
1
2005
55
0.070
Why?
Vagus Nerve Diseases
1
2002
1
0.060
Why?
Glucocorticoids
1
2007
538
0.060
Why?
Severity of Illness Index
3
2014
2817
0.060
Why?
Cough
1
2002
95
0.060
Why?
Amyloidosis
1
2001
41
0.060
Why?
Laryngeal Diseases
1
2001
25
0.060
Why?
Myasthenia Gravis
1
2001
18
0.060
Why?
alpha-Fetoproteins
1
2020
39
0.050
Why?
Cicatrix
1
2001
57
0.050
Why?
Parkinson Disease
1
2005
402
0.050
Why?
Middle Aged
7
2006
28678
0.050
Why?
Audiometry, Pure-Tone
2
1998
22
0.050
Why?
Gastroesophageal Reflux
1
2002
227
0.050
Why?
Adult
6
2006
31793
0.050
Why?
Drug-Related Side Effects and Adverse Reactions
1
2001
211
0.050
Why?
Drug Prescriptions
1
2001
260
0.050
Why?
Ear Neoplasms
1
1998
5
0.050
Why?
Hepacivirus
1
2020
210
0.050
Why?
Neurilemmoma
1
1998
21
0.050
Why?
Acute Disease
1
2001
997
0.050
Why?
Stroke
1
2005
916
0.040
Why?
Laryngoscopy
3
2002
69
0.040
Why?
Adipose Tissue
1
2001
664
0.040
Why?
Spinal Neoplasms
1
1996
27
0.040
Why?
Hearing Loss
1
1998
133
0.040
Why?
Reproducibility of Results
2
2014
2878
0.040
Why?
Speech Production Measurement
1
2014
14
0.040
Why?
Judgment
1
2014
61
0.030
Why?
Follow-Up Studies
3
2001
4888
0.030
Why?
Signal Processing, Computer-Assisted
1
2014
138
0.030
Why?
Area Under Curve
1
2014
328
0.030
Why?
Biomarkers, Tumor
1
2020
1041
0.030
Why?
Observer Variation
1
2014
333
0.030
Why?
Speech Perception
1
2014
83
0.030
Why?
ROC Curve
1
2014
486
0.030
Why?
Prospective Studies
2
2014
6168
0.030
Why?
Aged
4
2005
20026
0.030
Why?
Biomarkers
1
2020
3465
0.020
Why?
Predictive Value of Tests
1
2014
2021
0.020
Why?
Patient Selection
1
2012
692
0.020
Why?
Magnetic Resonance Imaging
2
1998
3019
0.020
Why?
Age Factors
1
1996
3330
0.020
Why?
Algorithms
1
2014
1548
0.020
Why?
Case-Control Studies
1
2014
3353
0.020
Why?
Cross-Sectional Studies
1
2015
4208
0.020
Why?
Age Distribution
1
2005
402
0.020
Why?
Sex Distribution
1
2005
395
0.020
Why?
Risk Assessment
2
2005
3137
0.020
Why?
Brain
1
1996
2664
0.020
Why?
Surveys and Questionnaires
1
2015
4550
0.020
Why?
Hoarseness
1
2001
4
0.010
Why?
Laryngeal Muscles
1
2001
5
0.010
Why?
Pyridostigmine Bromide
1
2001
3
0.010
Why?
Otorhinolaryngologic Surgical Procedures
1
2001
37
0.010
Why?
Cholinesterase Inhibitors
1
2001
23
0.010
Why?
Injections, Intramuscular
1
2001
127
0.010
Why?
Transplantation, Autologous
1
2001
195
0.010
Why?
Medical History Taking
1
2001
127
0.010
Why?
Biopsy, Needle
1
2001
196
0.010
Why?
Drug Therapy
1
2001
83
0.010
Why?
Steroids
1
2001
135
0.010
Why?
Retrospective Studies
3
2001
11118
0.010
Why?
Drug Utilization
1
2001
182
0.010
Why?
Incidence
1
2005
2453
0.010
Why?
Speech Reception Threshold Test
1
1998
4
0.010
Why?
Reflex, Vestibulo-Ocular
1
1998
9
0.010
Why?
Diagnosis, Differential
1
2002
1430
0.010
Why?
Evoked Potentials, Auditory, Brain Stem
1
1998
51
0.010
Why?
Child
1
1996
17358
0.010
Why?
Adolescent
1
1996
18579
0.010
Why?
Prognosis
1
2005
3532
0.010
Why?
Anti-Inflammatory Agents
1
2001
460
0.010
Why?
Chronic Disease
1
2002
1666
0.010
Why?
Aged, 80 and over
1
2005
6779
0.010
Why?
Practice Patterns, Physicians'
1
2001
1206
0.010
Why?
Risk Factors
1
2001
8979
0.010
Why?
Treatment Outcome
1
2001
8944
0.010
Why?
Abaza's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)